| pubmed-article:10761763 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10761763 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:10761763 | lifeskim:mentions | umls-concept:C0024305 | lld:lifeskim |
| pubmed-article:10761763 | lifeskim:mentions | umls-concept:C0092801 | lld:lifeskim |
| pubmed-article:10761763 | lifeskim:mentions | umls-concept:C0059985 | lld:lifeskim |
| pubmed-article:10761763 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:10761763 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10761763 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:10761763 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10761763 | pubmed:dateCreated | 2000-6-21 | lld:pubmed |
| pubmed-article:10761763 | pubmed:abstractText | It is unclear whether the purine analogs fludarabine (Flu) and cladribine (CdA) are non-resistant. | lld:pubmed |
| pubmed-article:10761763 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10761763 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10761763 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10761763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10761763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10761763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10761763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10761763 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10761763 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10761763 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:BonadonnaGG | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:ValagussaPP | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:SantoroAA | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:De PaoliAA | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:TondiniCC | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:LuoniMM | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:BalzarottiMM | lld:pubmed |
| pubmed-article:10761763 | pubmed:author | pubmed-author:RampinelliII | lld:pubmed |
| pubmed-article:10761763 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10761763 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:10761763 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10761763 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10761763 | pubmed:pagination | 231-3 | lld:pubmed |
| pubmed-article:10761763 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:meshHeading | pubmed-meshheading:10761763... | lld:pubmed |
| pubmed-article:10761763 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10761763 | pubmed:articleTitle | Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study. | lld:pubmed |
| pubmed-article:10761763 | pubmed:affiliation | Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy. tondini@istitutotumori.mi.it | lld:pubmed |
| pubmed-article:10761763 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10761763 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10761763 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10761763 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10761763 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10761763 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
